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Inotropic Effects of Salbutamol on Rat Diaphragm 
Contractility are Potentiated by Foreshortening
HENRICUS F. M. van der HEIJDEN, P. N. RICHARD DEKHUIJZEN, HANS FOLGERING, 
and CEES L. A. van HERWAARDEN
Department of Pulmonary Diseases, University Hospital Nijmegen, Nijmegen, The Netherlands
The aim of this study was to investigate whether the positive inotropic effects of the p2-adrenoceptor 
agonist salbutamol are increased by foreshortening of the diaphragm, and to determine the mecha­
nism of action of these effects. Diaphragm strips were studied either at optimal resting length (Lo) 
or at ~70% Lo. In an initial experiment (Experiment I) salbutamol was added to the tissue baths in 
concentrations of 10 ¿ig/L or 80 ng/L. In a second experiment (Experiment II), the effect of salbutamol 
(80 |ig/L) was measured in the presence of 1 p,M ryanodine, a sarcoplasmatic reticulum (SR) Ca2+- 
release inhibitor. Each experiment had a time-matched control group. Foreshortening reduced twitch 
force (Pt), maximal tetanic force (Po), and force-frequency curves. Salbutamol increased Pt and Po 
both at Lo and ^70% Lo. These inotropic effects were significantly greater after foreshortening. The 
force-frequency curve was shifted upward by salbutamol at both lengths. Force-frequency curves rel­
ative to maximal percent of Po were depressed by salbutamol at stimulation frequencies of 80 to 160 
Hz. Ryanodine blocked the inotropic effect of salbutamol at both muscle lengths, indicating that these 
inotropic effects are probably mediated by increased SR Ca2+ release, van der Heijden HFM, Dek- 
huijzen PNR, Folgering H, van Herwaarden CLA. Inotropic effects of salbutamol on rat diaphragm 
contractility are potentiated by foreshortening. am  j  re s p ir  c r i t c a r e  med 1997;155:1072- 1079.
Foreshortening of the diaphragm is present during acute hyperin­
flation, a condition frequently observed in patients with obstruc­
tive airways disease. Increasing lung volume from functional re­
sidual capacity (FRC) to total lung capacity (TLC) shortened the 
canine diaphragm by ~30% (1), and inflation from residual vol­
ume (RV) to TLC shortened the human diaphragm by ~40% 
(2). As a result of this foreshortening, transdiaphragmatic pres­
sure generation in humans decreased (3, 4). Furthermore, this 
decrease in force caused by shortening of diaphragm fiber lengths 
in vitro (5) and with increasing lung volumes in vivo (6) was shown 
to be augmented by fatigue.
Recent studies demonstrated that the inotropic effects of 
methylxanthines were augmented by foreshortening or hyperin­
flation. Gayan-Ramirez and colleagues found an increase in an­
imal diaphragm twitch-force (Pt) development in vitro (7, 8) and 
in vivo (9). Gauthier and associates described similar effects in 
healthy humans (4). These latter authors reported that aminoph- 
ylline also prevented the augmented decrease in force generation 
found after fatigue at high lung volumes (4).
It is unknown whether this increase in inotropic effect at short 
diaphragm lengths and the protection against fatigue are char­
acteristic of methylxanthines, or whether other inotropic agents, 
such as Pz-adrenoceptor agonists, exert similar effects. Both 
classes of agent are thought to increase Ca2+ release from the
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sarcoplasmic reticulum (SR) (10-12), but the inotropic effect of 
aminophylline was also influenced by extracellular calcium (13). 
Recently, we found that the (32-adrenoceptor agonist salbutamol 
improved diaphragm Pt, maximal tetanic force (Po), and sub- 
maximal tetanic force in vitro at optimal length (Lo) (14). We 
hypothesized that as with the findings for aminophylline, the 
inotropic effect of salbutamol is augmented by foreshortening 
of the diaphragm, and that improvement of SR Ca2+ release is 
likely to be involved. To test this hypothesis, we studied the in­
fluence of foreshortening on the inotropic effect of salbutamol 
on in vitro contractile properties of rat diaphragm strips both 
at Lo and at ~70(Vb Lo. In a second set of experiments, we inves­
tigated whether the inotropic effect of salbutamol could be 
blocked by the SR Ca2+-release inhibitor ryanodine.
METHODS
Animals and Study Design
Adult male outbred Wistar rats (n = 63), aged 18 wk and with a mean 
weight of 521 ± 6 (mean ± SE) g, were used. The animals were housed 
under standard conditions and were fed ad libitum. Animals were ran­
domly allocated to treatment groups. T\vo experiments were performed.
In the first experiment (Experiment I), 39 rats were studied in three 
treatment groups as follows: (/) time-matched controls (n = 13); (2) 
animals treated with salbutamol 0.03 |J.M (MO |xg/L) (n = 13); and (3) 
animals treated with salbutamol 0.3 fiM (~80 fig/L) (n = 13).
The second experiment (Experiment II) also consisted of three treat­
ment groups: (7) time-matched controls (n = 8); (2) animals treated with 
salbutamol 0.3 p,M (~80 |ig/L) and 1 nM ryanodine (n = 8); and (5) 
animals treated with 1 p,M ryanodine (n = 8).
Salbutamol (Glaxo-Wellcome BV, Zeist, The Netherlands) and ryano­
dine (Molecular Probes, Leiden, The Netherlands) were dissolved in Krebs 
solution immediately prior to each experiment. T\vo strips of diaphragm 
from each animal were mounted in tissue baths containing this solu­
tion, one strip at optimal resting length (Lo) and one at ~70% Lo.
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The various treatments in each experiment were performed in ran­
dom order; the investigator (H. vd H.) was blinded with regard to the 
treatments throughout the experiment. The study was approved by the 
Anim al Experiments Committee o f  the University o f Nijmegen.
General Procedure and Treatments
Similar protocols were used in both experiments to assess contractile 
properties. The rats were anesthetized with pentobarbital sodium (Nem­
butal [Apharmo, Arnhem, The Netherlands], 70 mg/kg intraperitonealiy). 
A  tracheotomy was performed and a polyethylene cannula was inserted. 
The animals were mechanically ventilated with 100% oxygen. The di­
aphragm and adherent lower ribs were quickly excised after combined 
laparotomy and thoractomy, and were immediately submersed in cooled, 
oxygenated Krebs solution at pH ~ 7 .4 . This Krebs solution consisted 
o f  (mM): 137 mM NaCl, 4 mM KC1, 2 mM CaCl2, 1 mM MgCl2, 1 mM 
KHjPO^, 24 mM N a H C 0 3, 7 mM glucose, and 25 |iM d-tubocurarine 
(Sigm a Chemicals, Bornem, Belgium). From the middle lateral costal
In these experiments we sought to limit the influence o f time-related 
fatigue on in vitro diaphragm force output. We therefore used a study 
design in which the two diaphragm strips obtained from each rat were 
studied simultaneously (one at Lo and one at ~70%  Lo). In this way, 
consecutive series of measurements on one strip, which might induce 
fatigue, were prevented. Additionally, at 37° C, there is a time-related 
decrease o f in vitro force production. Therefore, we used separate time- 
matched control groups in the two experimental protocols.
Measurement of Contractile Properties
In both Experiments I and II, the following protocols were performed: 
Twitch characteristics. TWo twitches were recorded at Lo to deter­
mine maximal Pt, contraction time (CT), and half relaxation time {Vi 
RT). Maximal Pt and the corresponding time characteristics were used 
for further analysis.
Maximal tetanic force. The bundles were stimulated twice at 160 Hz 
to obtain a plateau in force generation. The maximal force was defined
region o f  each hemidiaphragm, a rectangular strip was dissected paral- as the maximal tetanic force (Po).
lei to the long axis o f  the muscle fibers. Silk sutures were tied firmly 
to both ends o f the strip. The strips were suspended in two tissue baths 
containing Krebs solution, maintained at 37° C and perfused with a 
m ixture o f 95°7o 0 2 and 5% C 0 2. The central tendon end o f each strip 
was connected to an isometric force transducer (Model 31/1437-10; Sen- 
sotcc, Columbus, OH) mounted on a micrometer. Two large platinum 
stim ulating electrodes were placed parallel to the muscle strips. Stimuli 
were applied with a pulse duration o f 0.2 ms and a train duration o f  
250 m s, and were delivered by a stimulator (ID-electronics; University 
o f  N ijm egen, Nijm egen, The Netherlands) activated by a personal com ­
puter. To ensure supramaximal stimulation, the strips were stimulated 
at approxim ately 20% above the voltage at which maximal forces were 
obta ined  (~ 6  V applied through the stimulating electrodes). Data ac­
qu isition  and storage o f the amplified signal were done with a Dash-16 
interface (Twist-trigger software, ID-electronics, University of Nijme­
gen) on  a personal computer.
B oth  strips were placed at their optimal length (Lo), defined as the 
length  at which peak Pt was obtained. One strip (obtained from either 
the left or right hemidiaphragm) was selected in random order for fore­
shortening. The length o f this strip was measured in situ at Lo in the 
tissue bath, using a micrometer (Model 560-128; Mitutoyo, Veenendaal, 
T he Netherlands). Subsequently, this strip was placed at rW0% Lo and 
b oth  strips were stimulated twice (twitch contraction) to readjust them 
to their (new) length (7 ,8). No evidence o f twitch potentiation was found 
after these two twitch stimulations, nor after one maximal tetanic stim­
u lation  in a pilot experiment.
T h e salbutamol concentration o f 10 \xg/L in Experiment I was based 
on the mean human serum concentration reached after a single oral dose
Force-frequency characteristics. The bundles were stimulated at 2-min 
intervals at the following frequencies: 25, 50, 80,120, and 160 Hz. Both 
the absolute forces and the forces as percentages o f  Po were analyzed.
All o f these measurements were conducted within 20 min after the 
thermoequilibration period. Subsequently, the actual length (i.e., at 100% 
and ~70%  Lo, respectively), thickness, and width o f each diaphragm 
strip were measured. The strips were weighed and the cross-sectional 
area (CSA) was calculated by dividing diaphragm strip weight (g) by 
strip length (cm) times specific density (1.056). Forces were expressed 
per CSA (N/cm 2), and the Pt/Po ratio was calculated for each muscle 
strip.
Statistical Analysis
The salbutamol treatment effects were tested within each group o f di­
aphragm strip length in both experiments, using one-way analysis o f  
variance (ANOVA) followed by the Student-Newman-Keuls p o s t hoc 
test. To determine differences in salbutamol treatment effects between 
diaphragm strips at Lo and ~70%  Lo, a test criterion, T =  Z/SE(Z), 
was calculated (19). Z was calculated by subtracting the natural logarithms 
of the ratios o f salbutamol to control values at Lo and at ~70%  Lo
(Z ln{[slbLo -  C tlL o /c t lL o ]/[s lb 7oç„Lo -  Ctl7o«/oU>/ctl7o»/.Lo]b W ith sib
salbutamol and ctl = control). The SE(Z) was calculated with the 
A-method (19). Values o f p were obtained from standard normal distri­
bution tables. The effect o f foreshortening was analyzed with paired 
t tests within the control group o f  Experiment I. A  value o f p < 0.05 
was considered significant. Mean ± SE values are presented in the text, 
tables, and figures.
o f  4  mg, being M O  to 20 |ig /L  (15). The actual salbutamol concentra­
tion s were measured in five samples at 0.03 fiM and in five samples at
0.3 |.iM salbutam ol, using high-performance liquid chromatography 
(H P L C ) with fluorescence detection (Scotlab Analytical, Coatbridge, 
U K ). The salbutam ol concentrations were 10.1 ±  0.8 fig/L  and 78.3 ±  
4 .0  jxg/L, respectively. In a pilot study we found no effects of these sal­
b u ta m ol concentrations on the pH o f  the oxygenated Krebs solution
RESULTS
Experiment I
Diaphragm strip dimensions. In the Lo group, average diaphragm 
strip length, width, and thickness were 23.38 ± 0.35 mm, 2.97 ± 
0.05 mm, and 0.46 ± 0.01 mm, respectively. The average weight
(p H  ~ 7 .4  in all groups). A maximal increase in Pt was reached within of these strips was 48.5  ±  1.4 mg. No significant differences
10 m in  after addition o f  salbutamol, and lasted for at least 30 min. No  
differences in the time to maximal response or in the duration o f  maxi­
m al response were found between diaphragm strips at optimal length 
and  at ~ 7 0 %  Lo. Therefore, a period o f  15 min for thermoequilibra-
a
tion  and d iffusion  o f salbutamol was used in Experiments I and II.
Ryanodine in a concentration o f 1 p,M, as used in Experiment II, 
binds to the sarcoplasmatic reticulum (SR) Ca2+-release channels (ryano­
d in e  receptors), decreases their conductance, and reduces SR Ca2+ ac­
cu m u la tion  by locking these channels in an open subconductance state 
(16, 17). In a pilot experiment, the diffusion time o f ryanodine was found 
to  b e  significantly longer than the diffusion and thermoequilibration 
tim e o f  15 min needed for salbutamol. In these pilot experiments ryano­
d in e  (in a concentration o f  1 |xM) progressively decreased diaphragm
P t. After 30 minutes Pt was reduced to a level o f  ~50%  of initial Pt; 
n o  differences were found between strips at optimal length and fore­
shortened strips. In previous animal studies, similar diffusion times and 
levels o f force reduction were reported (12, 17, 18). Consequently, in Ex­
perim ent II, we used diffusion times o f  30 min for 1 nM ryanodine and
15 m in for salbutamol.
were found between the separate treatment groups at this length.
In the '■'-'70% Lo group, the length at Lo measured before short­
ening was similar to the values found for the Lo group. After 
foreshortening, the average strip dimensions were 17.66 ± 0.29 
mm, 3.34 ± 0.05 mm, and 0.58 ± 0.01 mm (length, width and 
thickness, respectively). Diaphragm strip weight in these fore­
shortened strips was 50.5 ± 1.3 mg. No significant differences 
between treatment groups were found, but length, width, and 
thickness were all significantly different when compared with 
the matching treatment group at Lo (p < 0.05; paired t test).
The mean actual percentage of foreshortening in this subgroup 
was 75.3 ± 0.5%, and was not significantly different between 
treatment groups. Although the strips in this subgroup were fore­
shortened to a level of ~70% Lo in the tissue bath, the length 
of the strip at the end of all measurements was approximately 
75% Lo in this experiment.
Twitch and maximal tetanic contraction. In the time-matched
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TABLE 1
TWITCH CHARACTERISTICS AND MAXIMAL TETANIC FORCE: EXPERIMENT I*
Lo
Control
10 ng/L salbutamol 
80 ng/L salbutamol 
^70%  Lo 
Control
10 ng/L salbutamol 
80 p.g/L salbutamol
Pt
(N/cm2)
7.45 ±0 .17 
8.27 ±0.23+ 
8.62 ± 0.20+
1.68 ± 0.09+ 
2.28 ±0.21 + 
2.54 ±0.16+
Ct
(ms)
I ~i r~ I |||>1I»~ m» T~l ■■ >||1VMM| - -II 'it)» —*•! •
25.6 ± 0.3 
26.3 ± 0.3 
26.5 ± 0.3
20.0 ± 0.3(+ 
20.6 ± 0.3
21.1 ± 0.2+
ViRT
(ms)
23.8 ± 0.6 
23.810.6 
25.1 ±0.7
14.3 ±0.6+
14.3 ±0.3 
13.6 ±0.2
-  r .
Po
(N/cm2)
- - r . <  H r  . -----------r -  P . » - * w -*
24.41 ± 0.74 
26.31 ±0.50 
26.93 ± 0.87+
11.15 ± 0.63+
14.56 ± 1.011
15.74 ±0.73+
Pt/Po Ratio
0.31 ± 0.01 
0.32 ± 0.01 
0.32 ± 0.01
0.15 ± 0.01 + 
0.16 ±0.01 
0.16 ± 0.01
Definition of abbreviations: Pt == peak twitch force; CT = contraction time; VkUT = half-relaxation time; Po = maximal tetanic force; Pt/Po = 
twitch to tetanic ratio; Lo -  optimal length.
* Values are mean ± SE (n = 13).
1" Values were significantly increased compared with control values at equal strip length (p < 0.05, one-way AN OVA).
$ Significant effect of foreshortening compared with control values at Lo (p < 0.001, paired t test).
control group, foreshortening reduced in vitro force generation 
to ~23%  of Pt at Lo, and to ~45%  of Po at Lo (p < 0.001; Table 
1). Likewise, the P t/Po  ratio, CT, and Vi RT were reduced by 
foreshortening (p < 0.001).
Salbutamol increased Pt and Po at both Lo and ~70% Lo. 
No significant differences were found between the two salbutamol 
concentrations. The Pt/Po ratio was not changed at either length. 
Salbutamol increased CT slightly at ~70% Lo; Vi RT was not 
altered (Table 1).
Salbutamol improved force generation to a greater extent at 
~70%  Lo than at Lo (Table 1 and Figure 1). Expressed as per­
centages of control values, salbutamol increased Pt at Lo by M l%  
and ~16% at 10 p.g/L and 80 [ig/L, respectively. At ~70% Lo, 
these increases were significantly greater than the responses at 
Lo, being ~34%  and 50%, respectively (p < 0.05 at 10 |ag/L 
and p < 0.01 at 80 ng/L, both compared with Lo; Figure 1). Simi­
lar differences between Lo and ~70% Lo were found for Po 
(Table 1 and Figure 1). Salbutamol effects were not signifi­
cantly different at Lo versus ~  70% Lo for CT, Vi RT, and P t/  
Po (Table 1).
Force-frequency characteristics: absolute force generation. 
Foreshortening largely depressed the force-frequency curve at 
all stimulation frequencies (p < 0.001, Figure 2). Salbutamol in­
creased force generation and caused an upward and leftward shift 
in force-frequency curves at both lengths (Figure 2). At Lo and 
~70% Lo, significant increases in absolute force production were 
found at stimulation frequencies of 25 and 50 Hz at both con­
centrations of salbutamol. Force generation at 80 |j,g/L sal­
butamol was significantly greater than at 10 |xg/L salbutamol 
at 25 Hz in the Lo group. At other frequencies, no differences 
were found between the two salbutamol concentrations. The in­
otropic effect of salbutamol on absolute force production was 
significantly greater at ~70%  Lo than at Lo for 50-Hz stimula­
tion only. No differences were found at other stimulation fre­
quencies.
Force frequency characteristics: force generation relative to 
maximal force generation. Force generation relative to maximal 
force generation (expressed as percentage of Po) in the foreshor­
tened diaphragm strips of the control animals was significantly
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Figure 1. Relative increase in twitch and maximal tetanic force gener- sent values at ~70% Lo. Circles represent control values, squares rep- 
ation after salbutamol, compared with control values; Experiment (I). resent 10 ja.g/Lsalbutamol, and triangles represent 80 p,g/L salbutamol. 
Hatched bars represent increase after 10 (j,g/L salbutamol, solid bars Significant increases with respect to control values within each length 
represent relative increase after 80 ^g/Lsalbutamol. Pt = peak twitch group (indicated by *) were found for both salbutamol concentra- 
force, Po = maximal tetanic force, Lo = optimal length. Compared tions at stimulation frequencies up to 50 Hz. Force output in the con- 
with Lo, significantly greater increases were found at ~70% Lo (*p < trol group at ~70% Lo was significantly reduced compared with Lo
0.05, * * p < 0.01). 001
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Figure 3. Force-frequency relation (relative to Po), Experiment (1). 
Open symbols represent values at optimal length (Lo), dosed symbols 
represent values at ~70% Lo. Circles represent control values, squares 
represent 10 fxg/L salbutamol, and triangles represent 80 ng/L sal­
butamol. * Values significantly increased or decreased by 10 fig/L and 
80 ng/L salbutamol as compared with control values at each length 
group (p < 0.05, one-way ANOVA). Relative force output in the con­
trol group at ~70% Lo was significantly reduced as compared with 
Lo at all frequencies (p < 0.001, paired t test).
reduced as compared with that at Lo (Figure 3). In the foreshor-
The average strip width and thickness were 3.65 ± 0.10 mm and 
0.62 ± 0.01 mm, respectively. Diaphragm strip weight in these 
foreshortened strips was 50.4 ± 1.8 mg. No significant differ­
ences between treatment groups were found, but length, width, 
and thickness were all significantly different from those of the 
matching treatment groups at Lo (p < 0.05, paired t test).
The actual percentage of foreshortening was 73.9 ± 0.9% in 
the control group; 70.5 ± 0.5% in the salbutamol-plus-ryanodine 
group and 71.0 ± 1.0% in the ryanodine group. Although the 
strips in this experiment were foreshortened through the same 
procedure as used in Experiment I, the degree of foreshortening 
was different in this experiment, and the overall strip length ap­
proximately matched the preset value of ~70%. Furthermore, 
as compared with the control group, the percentage of foreshor­
tening found in this group at the end of the protocol was signifi­
cantly different in both the salbutamol-plus-ryanodine group and 
in the ryanodine group (both p < 0.05; one-way ANOVA).
Twitch and maximal tetanic contraction. In the presence of 
ryanodine, salbutamol did not have any inotropic effect on Pt 
or Po at either Lo or ~70% Lo (Table 2). As compared with the 
time-matched controls in this experiment, coadministration of 
salbutamol and ryanodine significantly reduced Pt at both Lo 
and ~70% Lo. Po was significantly lower only at ~70%  Lo. As 
compared with the ryanodine group, a significantly higher Pt 
was found at Lo in the coadministration group, but Po was not 
affected at either length. The P t/P o  ratio was increased at ~70% 
Lo in both treatment groups (Table 2). Salbutamol in the pres­
ence of ryanodine reduced CT at rW0% Lo as compared with 
the control group. However, salbutamol plus ryanodine increased 
CT at both Lo and ~70% Lo as compared with the ryanodine
tened diaphragm strips, loss of force generation was observed group. The value of Vi RT was decreased in both the ryanodine
at the end of the protocol, resulting in a maximal level of 83% 
of Po. In contrast, diaphragm strips at Lo reached a level of 103% 
of Po (a significant difference between ~70% Lo and Lo, at p < 
0.001). In contrast to the positive inotropic effects on absolute 
force generation, salbutamol caused largely negative effects on 
relative force production (i.e., relative to maximal force genera­
tion; Figure 3). Only at Lo was relative force generation signifi­
cantly increased by salbutamol at a stimulation frequency of 25 
Hz, this increase being significantly greater at 80 |ig/L  than at
and salbutamol-plus-ryanodine groups, but did not differ between 
these two groups (Table 2).
Salbutamol in the presence of ryanodine did not affect Pt, 
Po, or twitch characteristics differently at ^70%  Lo than at Lo 
(Table 2 and Figure 4). Salbutamol plus ryanodine decreased Pt 
at Lo by ~20%, expressed as a percentage of control values; at 
~70% Lo this decrease was ~24%  (Figure 4). For Po these 
decreases were M 7%  and ^65%, respectively, but the differences 
in this case were not significant. However, in the ryanodine group,
10 jLLg/L (p < 0.05). However, at stimulation frequencies of 80 a significant difference was found between the relative effect at
to 160 Hz, salbutamol reduced the relative force output at Lo 
and augmented the reduction in relative force (%Po) induced 
by foreshortening (p < 0.05; Figure 3). As a result, the final 160- 
Hz stimulations at ~70%  Lo in the force-frequency curve pro­
duced a force output of ~75%  of Po at 10 ng/L and of n-'65% 
of Po at 80 |ig/L salbutamol, respectively (Figure 3). In com­
paring the two salbutamol concentrations, significantly greater 
reductions in relative force generation were found at 80 (ig/L 
at Lo, using a stimulation frequency of 120 Hz, and at ~70% 
Lo at stimulation frequencies of 80 to 160 Hz, suggesting a dose- 
dependent relationship. Additionally, the decrease in relative force 
production induced by salbutamol was significantly greater at 
~ 70 %  Lo than at Lo (10 i±g/L salbutamol: p < 0.05 at 120 and 
160 Hz; 80 p-S/T salbutamol: p < 0.01 at 80 Hz and p < 0.0001 
at 120 and 160 Hz, respectively).
Experiment II
Diaphragm strip dimensions. In the Lo group
Lo and at ~70% Lo for Po (p < 0.05; Figure 4).
Force-frequency characteristics: absolute force generation. 
Both at optimal length and after foreshortening, salbutamol in 
the presence of ryanodine decreased force production significantly 
at all stimulation frequencies as compared with control values 
(Table 3; p < 0.05 one-way ANOVA). Ryanodine alone also de­
pressed force production significantly as compared with the time- 
matched controls at both lengths. No differences were found be­
tween the salbutamol-plus-ryanodine group and the ryanodine 
group, but forces were mostly lower in the coadministration 
group. In contrast to the control animals, both treatments pro­
duced a decline in the force of subsequent contractions in the 
force-frequency protocol. This effect was most pronounced at 
~70%  Lo in the salbutamol-plus-ryanodine group, but was also 
present in the ryanodine group and at Lo. The relative treatment 
effect on absolute force production was significantly greater at 
~70%  Lo than at Lo at stimulation frequencies of 25 to 80 Hz 
(p < 0.01) and 120 Hz (p < 0.05) for salbutamol plus ryanodine,
strip length, width, and thickness were22.78 ± 0.29mm, 3.06 ± and at 50 to 120 Hz for ryanodine (p < 0.05).
0.09 mm, and 0.51 ± 0.01 mm, respectively. The average weight Force-frequency characteristics: force generation relative to
of these strips was 48.6 ± 1.6 mg. No significant differences were maximal force generation. At both lengths and treatment with
found between the separate treatment groups at this length. 
In the ~70% Lo group, the length at Lo measured before short
salbutamol plus ryanodine and with ryanodine alone largely 
depressed relative force production as compared with control
ening was similar to the values found for the Lo group. After values (i.e., relative to maximal force generation [%Po]; p < 0.05; 
foreshortening, the average strip length was 16.95 ± 0.34 mm. Table 4). Furthermore, as compared with ryanodine, salbutamol
1076 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 155 1997
TABLE 2
TWITCH CHARACTERISTICS AND MAXIMAL TETANIC FORCE: EXPERIMENT II*
Lo
Control
Salbutamol + ryanodine 
Ryanodine 
70% Lo 
Control
Salbutamol + ryanodine 
Ryanodine. . -----
* A " i  • .  I  • ■ » -  -  f  *
Pt
(N/cm2)
6.71 (0.27) 
5.40 (O.BB)tí: 
4.27 (0.40)t
2.23
1.70
1.45
(0.19) 
(0.18)t 
(0.09)1'
i  i ,  . .  .
b í  A . V t  V  —
Ct
(ms)
-V.. •- I.VM' -..fV—'
25.1 (0.7)
24.0 (0.4) $
22.0 (0.3)+
21.1
19.5
18.0
(0.3)
(0.3)++
(0.3)+
’/zRT
(ms)
25.1 (1.4)
21.1 (1 .1 )+ 
19.3 (1.0)+
17.4 (1.3) 
12.9 (0.4)+ 
12.8 (0.4)+
Po
(N/cm2)
21.79 (0.99) 
18.11 (3.96) 
15.97 (1.42)+
12.14 (1.32)
(0.96)+ 
(0.85)+
4.17
4.87
-----, ------------------.  « I  H . É  - f  f . . .  . r  , - W  ■  —  .  .
Pt/Po Ratio. ... .
0.31 (0.01) 
0.30 (0.01) 
0.27 (0.02)
0.19 (0.01) 
0.51 (0.07)++ 
0.34 (0.04)+
Definition of abbreviations: see table 1.
* Values are mean ± SE (n = 8). Salbutamol and ryanodine concentrations were 0.3 (.iM (80 jag/L) and 1 |aM, respectively.
t  p < 0.05 compared with control, 
t  p < 0.05 compared with ryanodine (one-way ANOVA),
plus ryanodine had greater negative effects at ~70% Lo at all 
but one stimulation frequency. At this length, force production 
was reduced to approximately zero at the end of the protocol 
in the salbutamol-plus-ryanodine treatment group. The treatment 
effect on relative force production ( % Po) was significantly greater 
at ~70°7o Lo than at Lo in the salbutamol-plus-ryanodine group 
at stimulation frequencies of 25 to 80 Hz (p < 0.001), 120 Hz 
( p < 0  .01), and 160 Hz (p < 0.05). In the ryanodine group, a simi­
lar result was found for stimulation frequencies of 50 to 160 Hz 
(p < 0.05).
DISCUSSION
The present study shows that foreshortening reduced force gen­
eration in strips of rat diaphragm, reducing Pt, Po, and the 
force-frequency curve. This reduction in force was in part reversed 
by salbutamol. Indeed, the inotropic effects of salbutamol on 
in vitro contractile properties of rat diaphragm strips were poten­
tiated by foreshortening, as shown by the significantly greater 
increases in both Pt and Po at ~70%  Lo than at Lo. Foreshor­
tening also reduced force production relative to maximal force
Pt Po
0
Lo 70% Lo Lo 70% Lo
O
coo
a>
CD
C
CO
-Co
-25
-50
-75
Figure 4. Relative increase in twitch and maximal tetanic force gener­
ation in Experiment II compared with control values. Crosshatched 
bars represent relative increase after 80 ng/L salbutamol in the pres-
production during the force-frequency protocol. Salbutamol aug­
mented this reduction, thus potentiating the “fatiguing” effect 
of foreshortening. In the presence of the SR Ca2+ release inhibi­
tor ryanodine, the inotropic effects of salbutamol were blocked 
and force production was reduced. During the force-frequency 
protocol, force production was progressively decreased. These 
findings indicate that the inotropic effects of salbutamol on di­
aphragm contractions are likely to be mediated by an increase 
in SR Ca2+ release.
Several mechanisms may be involved in decreasing force gener­
ation in foreshortened diaphragm. When skeletal muscle fibers 
were electrically stimulated at sarcomere lengths shorter than 75% 
of optimal length, a wavy configuration of central myofibrils 
was found (20). Failure of T-tubular propagation of membrane 
depolarization into core regions of the fibers is thought to be 
an explanation for this phenomenon and for fatigue. Further­
more, in foreshortened diaphragm muscle strips, force produc­
tion may also be reduced by an impairment of SR Ca2+ release 
(21). During high-frequency fatigue, reduced levels of intracel­
lular Ca2+ were found in core regions of single muscle fibers (22). 
This indicates that impaired T-tubular conduction not only leads 
to wavy myofibrils in muscle fiber core regions, but may also 
reduce Ca2+ release from the SR (21, 22). This is supported by 
findings made by Gauthier and coworkers (5), who showed that 
foreshortening and high-frequency fatigue had an additive ef­
fect in rat diaphragm strips: a larger decrease of in vitro tetanic 
force was found after fatigue at shorter muscle lengths (5). Simi­
lar effects were found in human diaphragm in vivo. When hu­
man lung volume increased, the maximal twitch transdiaphrag- 
matic pressure (Pdi) decreased linearly (3,4,6), and during fatigue 
a larger decrease in Pdi was found at high lung volumes (6). In 
our study, greater inotropic effects of salbutamol were found at 
shorter muscle lengths. In other words, a length-dependent reduc­
tion in force generation, possibly caused by a reduced SR Ca2+ 
release, was partially prevented by salbutamol. These effects were 
absent in the presence of ryanodine.
The mechanism of action of {32-adrenergic agonists on skele­
tal muscle has not yet been fully clarified. Recent studies have 
indicated that both methylxanthines and (32-agonists have simi­
lar intracellular effects in the diaphragm (10-12, 23). These ef­
fects may involve excitation-contraction (EC) coupling of skele­
tal muscle. The present experiments indicate that the inotropic 
effect of salbutamol is most probably mediated by an increase 
in this SR Ca2+ release. In Experiment II, coadministration of 
ryanodine prevented the inotropic effects of salbutamol, and force
ence of 1 fiM ryanodine; open bars represent relative increase after was reduced as compared with control values throughout the ex-
administration of ryanodine (1 jj.M) alone. Pt = peak twitch force, 
Po = maximal tetanic force, Lo = optimal length. *p < 0.05.
periment. At the concentration range used in our experiments, 
ryanodine reduces SR Ca2+ release by locking the calcium release
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TABLE 3
FORCE-FREQUENCY CHARACTERISTICS (SPECIFIC FORCES): EXPERIMENT II*
25 Hz 50 Hz 80 Hz 120 Hz 160 Hz
(N/cm2)
Lo
Control 9.83 (0.54) 18.53 (0.55) 22.41 (0.73) 23.08 (0.84) 22.83 (0.88)
Salbutamol + ryanodine 6.28 (0.70)+ 9.37 (1.20)+ 8.84 (1.47)+ 6.81 (1.57)+ 4.48 (1.31)+
Ryanodine 4.65 (0.61)+ 8.46 (1.28)+ 9.58 (1.52)+ 8.68 (1.53)+ 6.57 (1.32) +
70% Lo
Control 2.98 (0.28) 5.65 (0.60) 8.45 (0.99) 8.75 (1.04) 8.32 (1.02)
Salbutamol + ryanodine 0.55 (0.18)1* 0.51 (0.19)t 0.37 (0.16)1* 0.23 (0.11)1 0,12 (0.06)1*
Ryanodine 0.76 (0.12)+ 0.99 (0.20)+ 1.13 (0.30)+ 0.97 (0.28)+ 0.74 (0.23)+
* Values are mean ± SE, expressed in N/cm2; salbutamol and ryanodine concentrations were 0.3 (80 fig /l) and 1 j.iM, respec­
tively.
p < 0.05 compared with control (one-way ANOVA).
channels in an open subconductance state (16,17). As compared 
with the ryanodine treatment group, the salbutamol-plus-ryano­
dine group generated higher forces at Lo but lower forces at 70% 
Lo. Furthermore, during the force-frequency protocol, a progres­
sive decrease in force production was found, both at Lo and in 
foreshortened diaphragm strips. This may suggest a progressive 
depletion of the SR calcium pool, since ryanodine prevents the 
accumulation of Ca2+ in the SR (16). It could also indicate that 
salbutamol and ryanodine have additive effects on the mecha­
nism by which Ca2+ is released from the SR, and supports the 
hypothesis that the inotropic effects of (32-adrenoceptor agonists 
is mediated by an increase of SR Ca2+ release.
The proposed mechanism of action for the inotropic effect 
of salbutamol is in agreement with previous findings. Cairns and 
Dulhunty (24) showed that enhancement of sodium-pump ac­
tivity, dihydropyridine (DHP)-sensitive Ca2+ currents, glycoly­
sis, and altered action potentials are unlikely to be the mecha­
nisms o f action for the inotropic effect of the p2-adrenoceptor 
agonist terbutaline (24). Further studies with terbutaline indi­
cated that the increase in in vitro force induced by |}2-adrenoceptor 
agonists could be interpreted as a facilitation of EC coupling 
via enhanced Ca2+ release from the SR in both slow- and fast- 
twitch skeletal muscle fibers (11, 23). For example, addition of 
1 mM caffeine, which stimulates SR Ca2+ release, prevented an 
additional effect of terbutaline on force generation (11, 24), sug­
gesting that caffeine and terbutaline have a similar mechanism 
of action. Caffeine in concentrations below 5 mM also poten­
tiated P t and Po in both slow- and fast-twitch rat skeletal mus­
cles by enhancing SR Ca2+ release (10). These findings in mam­
malian skeletal muscle are in accord with the findings in earlier
experiments with frog skeletal muscle in which adrenaline treat­
ment potentiated twitch force by modulating calcium channels 
(25, 26).
Several studies suggested that SR Ca2+ release is modulated 
and regulated by phosphorylation of the complex interacting 
structure of voltage-dependent DHP receptors in the T-tubules 
and the SR Ca2+-release channels (ryanodine receptors) (27-29). 
The (32-adrenoceptor-mediated effects on force generation may 
also be mediated by an intracellular increase of cAMP (30). Ad­
ministration of cAMP can mimic the effects of terbutaline on 
skeletal muscle fibers in vitro (11, 24). In turn, this would sug­
gest a cAMP-mediated enhancement of SR Ca2+ release. Other 
potential mechanisms for the inotropic effect of J52-adrenoceptor 
agonists include phosphorylation of myosin heavy chains or my­
osin light chains, possible increasing Ca2+ sensitivity or Ca2+- 
activated force generation.
Foreshortening also potentiated the inotropic effects of ami- 
nophylline on respiratory muscle contraction. The studies by 
Gayan-Ramirez and coworkers (7-9) and by Gauthier and col­
leagues (4) found an increased inotropic effect of aminophyl- 
line on foreshortened diaphragm. This inotropic effect of amino- 
phylline on foreshortened canine diaphragm was also prevented 
by ryanodine, a SR Ca2+-release blocker (12). Compared with 
these effects of methylxanthines, the present study showed simi­
lar results for salbutamol, and suggests that these drugs have at 
least in part a similar mechanism of action. However, an impor­
tant discrepancy between the effects of aminophylline and sal­
butamol on diaphragm contractile properties is that salbutamol 
increased Po both at Lo and after foreshortening, whereas amino­
phylline did not increase Po at Lo at 37° C (31). This finding
TABLE 4
Lo
Control
Salbutamol + ryanodine 
Ryanodine 
70 % Lo 
Control
Salbutamol + ryanodine 
Ryanodine
FORCE-FREQUENCY CHARACTERISTICS (RELATIVE TO Po): EXPERIMENT II*
Twitch
31.0 (1.4) 
30.2 (0.9)
27.0 (1.6)
18.8 (1.0) 
50.9 (6.9)++ 
34.0 (3.8)+
25 Hz
45.3 (2.4)
34.7 (2.8)+
28.7 (1.8)+
25.1 (1.5) 
11.4 (1.9)+ 
15.8 (1.0)+
50 Hz
85.6 (2.0) 
51.5 (4.7)+ 
51.0 (4.5)+
47.3 (2.2) 
9.5 (2.6)++ 
19.6 (2.5)+
(% Po)
80 Hz
—I • «  —I  *—  m b '  1,  l \ .  «  a  " — |  4M  .  < * > •  ’  *  f - i  I ' l ' ' " /  (
103.2 (1.7)
48.2 (6.3) +
57.3 (5.9)+
69.7 (2.6) 
6.9 (2.5)++ 
21.1 (3.6)+
120 Hz
-•-.-I .<* ir 'v  *i *\t . ‘ ___________________________________ ______ ......................................... ,  . * i . -
- 1— .  M i l  .  ------------- . . f t '  .  .  ,1
* Values are mean±SE, expressed as %Po. Salbutamol and ryanodine concentrations were 0.3 H-M (80 j^g/L) and 1 iliM, respectively, 
t  p < 0.05 compared with control.
$ p < 0.05 compared with ryanodine (one-way ANOVA).
106.2 (1 3 ) 
36.5 (7.4)+ 
51.4 (6.5)+
72.4 (2.8) 
3.8 (1,7)++ 
18.0 (3.2)+
160 Hz
105.0 (1.2) 
23.9 (6.4)+ 
38.7 (6.0) +
O . o )  
( 1 .0)+* 
13.3 (3.1)+
68.7
2.3
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may indicate that cytosolic Ca2+ availability is limited during the percentages of Vc and Pdi (3) in healthy subjects. In contrast
to the effects of aminophylline, the present study showed a sig­
nificant inotropic effect of low, clinically relevant doses of sal­
butamol on Pt and Po at Lo. After foreshortening, a relatively
(in Experiment I); in other words, the force generated at the end greater inotropic effect was found. Therefore, it is likely that the
supramaximal electrical stimulations at physiologic temperatures.
Salbutamol increased in vitro diaphragm force production but 
reduced relative force generation in the force-frequency protocol
of the force-frequency protocol was lower than the initial Po, 
indicating some form of fatigue. This could be the result of a 
progressive depletion of the SR calcium pool by salbutamol treat­
ment, as was discussed earlier. An alternative explanation could 
be that salbutamol has its main effect on Type II muscle fibers 
in the rat diaphragm. Several findings support this contention. 
First, especially in Type Ilx /IIb  fibers, which are highly suscep­
tible to fatigue (32), a high binding affinity for p2-agonists was 
found (as measured by [12sI]cyanopindolol binding) (33). This 
higher binding affinity may override the previous finding that 
slow muscles (containing predominantly Type I muscle fibers) 
have a higher density of |32-adrenoceptors than do fast muscles 
(containing predominantly Type II muscle fibers) (34). Second, 
in fast- and slow-contracting skeletal muscles, opposing effects 
of catecholamines and (3-agonists have been reported both in vivo 
and in vitro (30, 35). In muscles containing predominantly Type
I (generally slow-contracting) muscle fibers, force production is 
reduced by catecholamines and P-agonists, whereas in fast mus­
cles, containing predominantly Type II muscle fibers, Pt and in­
complete tetanic force were increased (30,35). In the present study, 
salbutamol increased Pt, Po, and submaximal tetanic force, but 
reduced force generation relative to maximal force generation 
in the force-frequency protocol, indicating fatigue. These effects 
of salbutamol could be explained by a main effect on Type Ilx/IIb 
muscle fibers, which account for ~35%  of rat diaphragm mus­
cle (36).
Although the strips in the present study were foreshortened 
to 70% Lo at the start of the protocols, the actual level of fore­
shortening at the end of all measurements was ^75%  Lo in Ex­
periment I. This discrepancy may be explained by actual length­
ening of the strips during the protocol, or by the difference in 
the method of measuring length. The first length measurement 
at Lo and foreshortening of the diaphragm strips was performed 
in the tissue bath, whereas the final length measurement was per­
formed under dry conditions. In the second experiment, we there­
fore measured strip length before and after the stimulation pro­
tocol in the Lo group. In this group, the measured length at the 
end of all protocols did not differ from the measured length at 
the start of the protocols (98.7 ± 0.6%; not significantly differ­
ent between treatment groups). It is therefore likely that in fore­
shortened muscles, lengthening of these strips during the stimu­
lation protocols may have contributed to this difference in the 
degree o f foreshortening. A similar observation was made in the 
control group of the second experiment. However, in contrast 
to the first experiment, the degree of foreshortening in the sec­
ond experiment was close to the preset value of 70% Lo in the 
two groups treated with ryanodine. This difference can partly 
explain the force reduction in the presence of ryanodine that was 
found after foreshortening, but cannot explain the blockade of 
the inotropic effect of salbutamol found in the first experiment. 
This reduction in muscle length could indicate the development
o f contracture due to ryanodine treatment, and is in agreement 
with earlier observations in rat diaphragm (18).
In order to compare our results with those found for ami­
nophylline, we performed our experiments at ~75% Lo. This 
length reduction to ~75%  Lo approximately resembles acute 
hyperinflation from FRC to TLC (1,2). At intermediate muscle 
lengths, (e.g., 85% Lo), similar (although less pronounced) ef­
fects were found in terms of specific force reduction (37). Fur­
thermore, in human studies, a linear relation was found between 
the percentage of inspiratory capacity and Pdi (4), or between
force increase will also occur at intermediate lengths, and the 
relative increase will be intermediate to the increases found at 
Lo and ~75% Lo. Clearly, however, these effects need to be in­
vestigated in a clinical situation.
It is uncertain how applicable our in vitro results with healthy 
animal diaphragm are to clinical conditions in patients with ob­
structive airways disease (asthma and chronic obstructive pul­
monary disease [COPD]). The inotropic effects of salbutamol 
were present at a concentration of 10 |o,g/L. This concentration 
is reached in human serum after a single oral dose of 4 mg (15). 
Since predominantly slow motor units are recruited during nor­
mal ventilatory maneuvers in fresh diaphragm (38), stimulation 
of Type II muscle fibers by salbutamol would have no additive 
effect on diaphragm force generation in this situation. During 
fatigue, however, treatment with a p2-adrenoceptor agonist may 
increase diaphragm contractility in vivo, as was shown in ani­
mal studies for terbutaline (39), fenoterol (40), and broxaterol (41).
The present study may suggest that a similar positive effect 
of salbutamol may be expected in case of a foreshortened di­
aphragm, as may occur during acute hyperinflation in asthma 
or COPD patients. The increased fatigability observed during 
the force-frequency protocol in the present study would suggest, 
however, that salbutamol may be used for acute and short inter­
ventions only.
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